… Irritable bowel syndrome (IBS) is a heterogenous disease with a variety of therapeutic options,
… Choosing among the myriad treatment options requires attention to patient preferences …

Irritable bowel syndrome (IBS) is a chronic functional bowel disorder affecting 5.7% of the
general population. Most patients relate their symptoms of IBS to foods they consume with diet …

… . A systematic review and meta-analysis evaluating the efficacy of a gluten-free diet and a
low FODMAPs diet in treating symptoms of irritable bowel syndrome. Am J Gastroenterol 2018;…

… Irritable bowel syndrome is common, affecting 3.7% of men and 7.8% of women in Canada,
… Irritable bowel syndrome is also associated with increased work absenteeism and poor work …

… to treat global IBS with constipation symptoms. We recommend the use of rifaximin to treat
global IBS … We suggest that gut-directed psychotherapy be used to treat global IBS symptoms. …

… treatment options for patients with chronic idiopathic constipation and irritable bowel syndrome
… approved in the United States for the treatment of irritable bowel syndrome with diarrhea. …

… , treating patients is often described as a process of trial-and-error. No treatment option fits
… In this review, we will focus on the pharmacological treatment options for patients with IBS-D…

… with existing prescription treatment options/OTC treatment options for IBS-D/… treatment
options for IBS, physicians were asked, Do you recommend any of the nonpharmacologic options …

… The currently available treatment options, both … possible treatment options for IBS, which
would help to treat … The objective of this review is to focus on the treatment options for IBS and …

… for chronic idiopathic constipation and irritable bowel syndrome with constipation, outlining
how these mechanisms contribute to the efficacy and safety of each treatment option. …